Federal Register / Vol. 71, No. 206 / Wednesday, October 25, 2006 / Notices 62477 

Dated: October 18, 2006. 

Suzanne Freeman, 

NHLBI Project Clearance Liaison, National 

Institutes of Health. 

Dated: September 26, 2006. 

Peter Savage, 

Acting Director, DPPS, National Institutes of 

Health. 

[FR Doc. E6–17898 Filed 10–24–06; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director, National 

Institutes of Health; Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

Director’s Council of Public 

Representatives. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: Director’s Council of 

Public Representatives. 

Date: November 3, 2006. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: Among the topics proposed for 

discussion are: (1) NIH Director’s update: (2) 

Discussion on the Role of the Public in the 

Research Process; (3) Genome-Wide 

Association Studies Briefing; (4) NIH 

Foundation Activities Report; (5) Update on 

Biomarkers of Disease; (6) NIH 

Communications Update; and (6) discussion 

and public comment. 

Place: National Institutes of Health, 

Building 31, Conference Room 6, 9000 

Rockville Pike, Bethesda, MD 20892. 

Contact Person: Jennifer E. Gorman, NIH 

Public Liaison/COPR Coordinator, Office of 

Communications and Public Liaison, Office 

of the Director, National Institutes of Health, 

9000 Rockville Pike, Building 31, Room 

5B64, Bethesda, MD 20892, (301) 435–4448, 

gormanj@od.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel and airport shuffles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state he purpose of their 

visit. Information is also available on the 

Institute’s/Center’s home page http:// 

www.copr.nih.gov, where an agenda and any 

additional information for the meeting will 

be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.14, Intramural Research 

Training Award; 93.22, Clinical Research 

Loan Repayment Program for Individuals 

from Disadvantaged Backgrounds; 93.232, 

Loan Repayment Program for Research 

Generally; 93.39, Academic Research 

Enhancement Award; 93.936, NIH Acquired 

Immunodeficiency Syndrome Research Loan 

Repayment Program; 93.187, Undergraduate 

Scholarship Program for Individuals from 

Disadvantaged Backgrounds, National 

Institutes of Health, HHS) 

Dated: October 17, 2005. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–8882 Filed 10–24–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given on the meeting of the 

President’s Cancel Panel. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in section 

552b(c)(9)(B), Title 5 U.S.C., as 

amended, because the premature 

disclosure of information and the 

discussions would likely to significantly 

frustrate implementation of 

recommendations. 

Name of Committee: President’s Cancer 

Panel. 

Date: December 5, 2006. 

Open: December 5, 2006, 8 a.m.–4 p.m. 

Agenda: Promoting Healthy Lifestyles to 

Reduce the Risk of Cancer. 

Place: Oregon Health & Science University 

Cancer Institute, 3181 Southwest Sam 

Jackson Park Road, Portland, OR 97239. 

Closed: December 5, 2006, 4 p.m.–8 p.m. 

Agenda: The Panel will discuss the 

Promoting Healthy Lifestyles to Reduce the 

Risk of Cancer and discuss potential topics 

for the 2007/2008 series. 

Place: Oregon Health & Science University 

Cancer Institute, 3181 Southwest Sam 

Jackson Park Road, Portland, OR 97239. 

Contact Person: Abby Sandler, PhD, 

Executive Secretary, National Center 

Institute, National Institutes of Health, 

Building 6116, Room 212, 6116 Executive 

Boulevard, Bethesda, MD 20892, 301/451–

9399. 

Any interested person may file written 

comments with the committee by forwarding 

the comments to the Contact Person listed on 

this notice. The comments should include 

the name, address, telephone number and, 

when applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: 

deainfo.nci.nih.gov/advisory/pcp/pcp.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: October 17, 2006. 

Linda Payne, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–8883 Filed 10–24–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, 

mstockstill on PROD1PC61 with NOTICES